{
    "nctId": "NCT03919214",
    "briefTitle": "Hypertension Management in Cancer Patients",
    "officialTitle": "Hypertension Management in Cancer Patients: Bringing PCPs \"Back\" Into Cancer Care",
    "overallStatus": "TERMINATED",
    "conditions": "Blood Pressure, Hypertension, Cancer, Cancer, Breast, Cancer of Prostate, CLL, Hematopoietic Malignancy",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 4,
    "primaryOutcomeMeasure": "Patient Adherence",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* A total of 40 patients with a diagnosis of hypertension who are 18-74 years old who fall under the following criteria will be screened:\n\n  * 10 women with Stage I-III breast cancer who are on active cancer therapy and are receiving either an anthracycline (doxorubicin) or antiHER2 (trastuzumab or pertuzumab)\n  * 10 men with prostate cancer on androgen deprivation therapy (ADT)\n  * 10 individuals with CLL on ibrutinib therapy\n  * 10 HSCT survivors (who had a malignancy)\n  * Have a smartphone (iPhone or Android)\n  * Have a Duke primary care provider and Duke oncologist (who is being treated at the Duke Cancer Center)\n  * Have access or willing to set up access to Duke MyChart.\n  * English speaking patients",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}